Davide Ruggero
Profile
Davide Ruggero is the founder of eFFECTOR Therapeutics Operations, Inc. and eFFECTOR Therapeutics, Inc., both founded in 2012.
Former positions of Davide Ruggero
| Companies | Position | End |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Founder | - |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Founder | - |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Davide Ruggero
